Our top pick for
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
ENDRA Life Sciences Inc is a diagnostics & research business based in the US. ENDRA Life Sciences shares (NDRA) are listed on the NASDAQ and all prices are listed in US Dollars. ENDRA Life Sciences employs 15 staff and has a market cap (total outstanding shares value) of USD$21.3 million.
|Latest market close||USD$0.8768|
|52-week range||USD$0.599 - USD$2.25|
|50-day moving average||USD$0.7531|
|200-day moving average||USD$0.8455|
|Wall St. target price||USD$5.17|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$-1.632|
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-01-08)||-4.70%|
|1 month (2020-12-16)||15.98%|
|3 months (2020-10-15)||22.63%|
|6 months (2020-07-15)||-1.92%|
|1 year (2020-01-15)||-48.73%|
|2 years (2019-01-15)||-53.61%|
|3 years (2018-01-12)||3.63|
|5 years (2016-01-12)||N/A|
|Gross profit TTM||USD$0|
|Return on assets TTM||-172.37%|
|Return on equity TTM||-602.99%|
|Market capitalisation||USD$21.3 million|
TTM: trailing 12 months
There are currently 522,891 ENDRA Life Sciences shares held short by investors – that's known as ENDRA Life Sciences's "short interest". This figure is 12.7% down from 598,877 last month.
There are a few different ways that this level of interest in shorting ENDRA Life Sciences shares can be evaluated.
ENDRA Life Sciences's "short interest ratio" (SIR) is the quantity of ENDRA Life Sciences shares currently shorted divided by the average quantity of ENDRA Life Sciences shares traded daily (recently around 144047.10743802). ENDRA Life Sciences's SIR currently stands at 3.63. In other words for every 100,000 ENDRA Life Sciences shares traded daily on the market, roughly 3630 shares are currently held short.
However ENDRA Life Sciences's short interest can also be evaluated against the total number of ENDRA Life Sciences shares, or, against the total number of tradable ENDRA Life Sciences shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case ENDRA Life Sciences's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 ENDRA Life Sciences shares in existence, roughly 20 shares are currently held short) or 0.0229% of the tradable shares (for every 100,000 tradable ENDRA Life Sciences shares, roughly 23 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against ENDRA Life Sciences.
Find out more about how you can short ENDRA Life Sciences stock.
We're not expecting ENDRA Life Sciences to pay a dividend over the next 12 months.
Over the last 12 months, ENDRA Life Sciences's shares have ranged in value from as little as $0.599 up to $2.25. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while ENDRA Life Sciences's is 1.6017. This would suggest that ENDRA Life Sciences's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
ENDRA Life Sciences Inc. develops technology for clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood for the treatment of nonalcoholic fatty liver disease, as well as temperature monitoring of thermoablative surgery, vascular imaging, and tissue perfusion. It also offers diagnostic imaging technologies, such as computed tomography, magnetic resonance imaging, and ultrasound that allow physicians to look inside a person's body to guide treatment or gather information about medical conditions, such as broken bones, cancers, signs of heart disease, or internal bleeding. The company has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.
Everything we know about the CDT Environmental Technology Investment Holdings Limited IPO, plus information on how to buy in.
Everything we know about the Viant Technology Inc IPO, plus information on how to buy in.
Steps to owning and managing EVGN, with 24-hour and historical pricing before you buy.
Steps to owning and managing ETL, with 24-hour and historical pricing before you buy.
Steps to owning and managing EQBK, with 24-hour and historical pricing before you buy.
Steps to owning and managing EIGI, with 24-hour and historical pricing before you buy.
Steps to owning and managing ELTK, with 24-hour and historical pricing before you buy.
Steps to owning and managing DNKN, with 24-hour and historical pricing before you buy.
Steps to owning and managing DKL, with 24-hour and historical pricing before you buy.
Steps to owning and managing DMAC, with 24-hour and historical pricing before you buy.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.